, 64 isolates of Pseudomonas aeruginosa were implicated in bacteraemia in 25 cancer patients in five wards of two hospitals. These, together with 24 environmental isolates and one isolate from a bacteraemia in a noncancer patient were examined by three PCR-based DNA fingerprinting methods: random amplified polymorphic DNA (RAPD), enterobacterial-repetitive intergenic consensus (ERIC)-PCR, and 16s-23s spacer region-based RAPD. These methods were reproducible, discriminatory and showed close agreement; all indicated that 47 isolates that had caused bacteraemia in 19 cancer patients were indistinguishable. Seventeen other isolates that had caused bacteraemia in 10 cancer patients were discriminated into eight further groups, and the 24 environmental and non-cancer patient isolates into further distinct groups. No environmental source of the epidemic strain was found, but it was suspected that the outbreak was related to infusion implants.
Introduction
Pseudomonas aeruginosa is an opportunist pathogen frequently isolated in the hospital from moist environmental sources and equipment [ 11. Septicaemic infections are an important cause of mortality in immunocompromised patients [2] , particularly in neutropenic cancer patients [I] . Investigations of the nosocomial epidemiology of f( aeruginosa have been hampered by the inadequate discriminatory capacity of classical phenotypic methods such as serotyping, phage typing, pyocin typing and biotyping. Modern DNAbased techniques, including restriction fragment length polymorphism (RFLP) demonstrated by hybridisation with species-specific coding regions such as the exotoxin A gene, the pilin gene and a broad-spectrum probe of Escherichia coli macrorestriction analysis by pulsed-field gel electrophoresis (PFGE) [5, 8-1 01 or field inversion gel electrophoresis (FIGE) [ 1 1, 121 and restriction endonuclease analysis (REA) [ 131 have been applied in epidemiological studies of P Of the PCR-based techniques, random amplified polymorphic DNA (RAPD) [14] is based on the amplification of DNA segments with a single primer of arbitrary nucleotide sequence, and has been widely used for the epidemiological investigation of many micro-organisms [ 1 51 including I? aeruginosa [ 10, 16, 1 71 . The 126-bp enterobacterial repetitive intergenic consensus (ERIC) elements contain a highly conserved central inverted repeat located in extragenic regions; this has been used as a primer in PCR (ERIC-PCR) to obtain DNA fingerprints for several bacterial species [18, 191 . The spacer regions separating the genes coding for 16S, 23s and 5s rRNA are characterised by a high degree of sequence variation at the genus and species level [20] . The diversity is mainly due to variations in the number and type of tRNA sequences found within the spacer. PCR amplification of spacer regions between the 16s and 23s RNA genes has been used for characterisation of a broad range of bacteria [20] . Spacer region PCR products of Mycobacterium tuberculosis strains have been used as target DNA for RAPD amplification that gave discriminatory results [2 11.
In this study, RAPD, ERIC-PCR and 16s-23s spacer region polymorphism-based RAPD analysis were compared in the investigation of a possible outbreak of P aeruginosa bacteraemia in cancer patients in two hospitals in Marseille.
Materials and methods

Isolates and patients
A total of 89 I? aeruginosa strains was selected for investigation. Sixty-four isolates from 25 cancer patients were implicated in bacteraemic episodes between July 1994 and March 1995. These patients had various malignancies, including breast cancer, cerebral tumour, lymphoma, hepatocellular carcinoma and uterine cancer, and all developed bacteraemia during chemotherapy administered via an infusion implant. They were in five wards (oncology, radiotherapy, gynaecology, dermatology and neurosurgery) at two hospitals. A further 24 strains from the hospital environment (water, siphon and surfaces) in these five wards, and one isolate implicated in bacteraemia in a non-cancer patient with no infusion implant, who was hospitalised for surgery in another ward, were collected during the same period.
IdentiJication, susceptibility testing and 0 serotyping
All isolates were identified as P aeruginosa according to colony morphology, Gram's stain appearance, oxidase reaction, growth at 4 1 "C, and reaction patterns in the API 20 NE system (bioMerieux, Marcy I'Etoile, France) and API 100 carbon auxanogram strips (bioMerieux). Antibiotic susceptibility testing was performed with the Walkaway 40 System (SanofiDiagnostics Pasteur, Marnes-la-Coquette, France). 0 serotypes were determined by the International Antigenic Typing System (Diagnostic Pasteur) [22] . Reactions with commercial 0 antisera were controlled with reference strains.
DNA extraction
Isolates were grown in trypticase-soya broth at 37°C for 24 h and DNA was extracted by the Chelex technique as described by De Lamballerie et al. [23] .
RAPD and ERIC-PCR conditions
Amplification reactions were performed in a total volume of 47pl containing 1 0 0~~ each of dATP, dCTP, dGTP and dTTP, 0 . 2~~ of primer AP12H (5'-CGGCCCCTGT-3 ') or ERIC-2 (5 '-AAGTAAGT-GACTGGGGTGAGCG-3'), 25 ng of template DNA and 1.25 units of Taq polymerase (Perkin-ElmedCetus, Nonvalk, CT, USA) in PCR buffer (20 mM Tris-HC1, pH 8.3; 50 mM KC1, 2.5 mMMgC12). A negative control without template DNA was. included in each experiment. The reaction mixtures were overlaid with mineral oil and subjected to amplification in a DNA thermal cycler (TR 2, Cera-Labo, Aubervilliers, France) programmed for 45 cycles of 1 min at 94"C, 1 min at 45°C and I min at 74°C. After the last cycle, samples were maintained at 74°C for 10 min. Amplification products were compared by electrophoresis of 10-pl samples on agarose 1.2% gels (Eurogentec, Angers, France) in Tris-acetate buffer (0.04 M Trisacetate, 0.001 M EDTA, pH 8.2), stained with ethidium bromide and photographed on a UV light transilluminator. The presence or absence of bands in a gel lane was determined by visual inspection of the patterns independently by two observers. Fingerprint patterns were interpreted without knowledge of epidemiological data. Fingerprint patterns were considered similar (indistinguishable) if all bands had the same migration distance or if there were no more than two band differences for patterns comprising 6-1 1 products or three band differences for patterns comprising 12-I 8 products. These criteria for classifying isolates as indistinguishable or different were established in previous studies [24, 251. Variation in intensity and shape of bands were not considered to be differences. In addition, photographs of the gels were scanned and analysed with a Bio Image wholeband system, Scanner 3+ (Millipore). Mol. wt standards were included (Marker V, Boehringer, Boehringer Mannheim, Germany). The mol. wts of sample bands were calculated automatically from reference bands allowing evaluation of mol. wts to c. 1%.
PCR ampliJication of 165-23s spacer region and RAPD based upon this region
PCR was performed as follows: a 50-pl volume of reaction mixture containing 25 ng of isolate DNA, 50 mM KC1, 10 mM Tris-HC1 (pH 829, 1.5 mM MgC12, Triton X-100 0.1 %, 100 p~ of each deoxynucleotide triphosphate (Boehringer Mannheim), 62.5 ng of each of two oligonucleotide primers G 1 (5 '-GAAGTCG-TAACAAGG-3') and LI (5'-CAAGGCATCCACCGT-3') previously selected [20] and 1.3 units of Taq DNA polymerase (Perkin-Elmer/Cetus) was subjected to 25 amplification cycles of denaturation at 94°C for 1 min, annealing at 55°C for 7 min and extension at 72°C for 2 min. After the last cycle, samples were maintained at 72°C for 7 min. The PCR products (10 p1) were separated by electrophoresis on agarose 1.2% gel (Eurogentec, Angers) in Tris-acetate buffer (0.04 M Tris-acetate, 0.001 M EDTA, pH 8.2). The gels were stained with ethidium bromide and photographed on an UV light transilluminator. A mol.wt standard was included (Marker V, Boehringer). The remaining PCR product was precipitated with ethanol and resuspended in TE buffer (10 mM Tris-HC1, pH 8.0, 1 mM EDTA) for use as target DNA for RAPD; 15 ng of this, and 0.25 p~ of primer AP12H or AP4 (5'-TCA CGA TGC A-3 '), were amplified under the conditions described above for RAPD.
Reproducibility of DNA jingerprints
Fingerprint profiles generated from independent DNA preparations extracted from single-colony cultures at different times and amplified separately were run side by side on an agarose gel to determine the reproducibility of the three PCR-based DNA fingerprinting methods.
Identijcation
All isolates grew at 41°C. Colonies from the 47 clinical isolates were rough and dwarf after growth for 24 h on blood agar. They were identified as P aeruginosa with the API 20 NE system and all clinical isolates yielded the same pattern (0154575). All isolates showed the pattern characteristic of I? aeruginosa in API 100 carbon auxanogram strips.
Antibiograms
All clinical isolates were susceptible to azlocillin, piperacillin, ticarcillin, cefsulodin, ceftazidime, aztreonam, imipenem, gentamicin, tobramycin, amikacin and ciprofloxacin. They were of intermediate susceptibility to moxalactam, cefoperazone and aztreonam, and resistant to chloramphenicol and trimethoprim-sulphamethoxazole.
Se ro typ ing
All clinical strains were non-agglutinable. Of the 24 environmental isolates, eight were of serotype 06, two of serotype 0 1 , one of serotype 010 and one of serotype 0 12; three were non-agglutinable and nine were polyagglutinable.
PCR analyses
In RAPD with the AP12H primer, nine distinct patterns were found. RAPD pattern 1 comprised 48 cancer patient isolates; patterns 2-5 comprised the remaining 16 isolates from cancer patients. The non-cancer patient isolate belonged to RAPD pattern 6, and the 24 environmental isolates yielded patterns 7, 8 and 9 ( Fig. 1; Table 1 ).
ERIC-PCR yielded 12 typing patterns. Pattern 1 comprised 5 1 cancer patient isolates; patterns 2-8 comprised the remaining 13 cancer patient isolates. The non-cancer patient isolate gave pattern 9 and the 24 environmental isolates yielded three further patterns ( Fig. 2; Table 1 ).
Fig. 1.
Representative paired replicate lanes of the nine RAPD types obtained with primer AP12H. Each strain was selected to represent a specific type. Types 1-5 were clinical isolates; type 6 was a clinical control strain; types 7-9 were environmental isolates. Lane M, mol. wt marker (bp). All isolates shared three common fragments of 356, 570 and 1033 bp in the 16s-23s spacer region amplification products and were indistinguishable (data not shown).
However, when RAPD with AP4 primer was performed with the amplified spacer products as the target, nine patterns were resolved. Pattern 1 comprised 47 cancer patient isolates; patterns 2-6 comprised the remaining 17 cancer patient isolates. The non-cancer patient isolate gave pattern 7 and the 24 environmental isolates were distributed among typing patterns 8 and 9 ( Fig. 3 ; Table 1 ).
The profiles obtained with AP4 primer RAPD of the spacer-region products were less complex and easier to interpret than those obtained with RAPD of whole-cell DNA, or ERIC-PCR. However, RAPD of the spacer product with primer AP 12H yielded a single uniform pattern, so the choice of the primer seems to be critical.
Reproducibility of DNA jngerprints
The reproducibility of fingerprint profiles from different DNA preparation of the same strain was investigated by analysis of DNA from separate cultures extracted at different times. In each case, identical profiles were generated, although differences in band intensity were present.
Combined interpretation of the results of the three jngerprint methods
The results showed good agreement. In combination, the three methods allowed classification of the isolates into 13 groups. Group I comprised 47 isolates from 19 cancer patients in five wards of the two hospitals. Groups 11-IX comprised the remaining 17 cancer patient isolates. Fig. 4 shows the distribution of the 64 clinical isolates in the five wards. The non-cancer patient isolate belonged to group X (Table 1 ). The 24 environmental isolates were distributed among three other groups (data not shown), and were considered to be clearly different from the clinical strains.
Epidemiological investigation
During 8 months, an epidemic type of I? aeruginosa was responsible for bacteraemia in 19 cancer patients during their chemotherapy. The results of this study Fig. 3 . Representative paired replicate lanes of the nine RAPD profiles with primer AP4 of the 16s-23s spacer region products of l? aeruginosa isolates. Types 1-6 were clinical isolates; type 7 was a clinical control strain; types 8 and 9 were environmental isolates. Lane M, mol. wt marker (bp). , Ill; m, IV; , v; , VIII; , of bacteraemic P aeruginosa isolates from 25 cancer patients between July 1994 symbol corresponds to a specific combined group: a, 1; , VI(N) or VII(R); 0, 11;
IX. N, neurosurgery ward; R, radiotherapy; 0, oncology; G, gynaecology; D, indicated that the P aeruginosa bacteraemia cases might be related to the presence of infusion implants. These were implanted by two surgeons who shared the same materials and antiseptic solutions in the same unit. Contamination from the hands of one or both surgeons, the shared equipment or an environmental source could have explained the outbreak. However, no positive fingertip impression cultures from the surgeons, environment samples or equipment samples fragment patterns after restriction endonuclease cleavage [ 131. Difficulties in interpretation of the complex banding patterns led to the use of specific gene probes or rare-cutting restriction endonucleases to generate patterns with few fragments. Chromosomal fingerprinting with DNA probes or macrorestriction analysis by pulsed-field gel electrophoresis (PFGE) have been employed for epidemiological typing of P aeruginosa [4-121. However, Grundmann et af. were the first to were obtained. As bacteraemia cases were observed 2 compare the discriminatory power and the reproduciweeks-6 months after surgical implantation of the bility of hybridisation of restricted chromosomal DNA devices, contamination could have occurred during with a specific (tox A) probe, ribotyping and PFGE [ 5 ] . manipulation of infusion implants for the administraThey concluded that PFGE was the most powerful tool tion of anticancer therapy. However, bacteriological for studying the epidemiology of P aeruginosa because culture of some infusion implants removed from of its high discriminatory capacity, good reproduciinfected patients did not yield P aeruginosa. Similarly, bility and ease of interpretation. Moreover, Martin et P aeruginosa was not isolated from anticancer therapy af. [7] used ribotyping for molecular typing of strains infusates. No other case of I? aeruginosa bacteraemia of P aeruginosa from patients with cystic fibrosis and was observed in these patients and the outbreak observed a low degree of heterogeneity of rRNA stopped after hospital personnel were informed about operons. They considered that ribotyping would not be the risk of bacterial contamination during implantation a valuable method for epidemiological studies with P and manipulation of infusion implants.
aeruginosa.
At the same time, the labour-intensive nature of [26, 271. Combination of the results of the three methods suggested that most of the l? aeruginosa isolates causing bacteraemia in cancer patients were indistinguishable and represented an epidemic clone. It also showed that the 24 isolates from the environment of the cancer patients were dissimilar from the isolates causing bacteraemia. Consequently, no environmental reservoir of the outbreak strain was found, although it was suspected that the outbreak was related to infusion implants.
RAPD and ERIC-PCR are generally used together in our laboratory and they always gave results in close agreement. The results of this study have shown that the analysis of polymorphism of the 16S-23s RNA spacer region by RAPD is a useful alternative, despite the requirement of a double procedure. Despite problems of reproducibility, which can be circumvented with experience, RAPD and ERIC-PCR are very useful in the epidemiological investigation of nosocomial outbreaks of l? aeruginosa infection for most clinical laboratories.
In conclusion, the three PCR-based typing methods showed similar discrimination for I?< aeruginosa isolates. PCR-based typing methods were simple to do and to interpret and had the advantages of typability and discriminatory capacity equivalent to macrorestriction analysis.
